Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Pharmachem launches new diabetes management product
The ingredients have shown to lower both circulating glucose and insulin levels after consumption of a 70-gram sucrose challenge, compared to placebo, in two separate human studies. The
The ingredients have shown to lower both circulating glucose and insulin levels after consumption of a 70-gram sucrose challenge, compared to placebo, in two separate human studies. The
The all-servo driven case packer, which utilizes indexing motion to load up to 25 cases per minute, features white powder coat or specified machine finish and redundant quality
Last week the company initially announced the 8-year government distribution contract with the Office of Health Affairs (OHA), a branch of the US. Department of Homeland Security has
Based in Denver, Natural Grocers is a grocery chain that offers only natural and organic dietary supplement, home and body care products. The grocery also offers USDA certified
As part of the agreement, Katama will initially develop tolperisone to treat acute, painful muscle spasms. Tolperisone has a new dual mechanism of action that acts on the
Watson president and CEO Paul Bisaro said,"Approval from the EC represents a significant milestone as we work toward the completion of the combination of Watson and Actavis later
Glenmark Pharmaceuticals and Aurobindo Pharma have already begun to use Goose Proofreader, according to the company. Goose Proofreader is designed to make the artwork error free there by
The agreement will leverage the enzyme platform technologies, services and expertise for the manufacturing of active pharmaceutical ingredients. DSM Pharmaceutical Products CEO Alexander Wessels said, "Via this agreement,
Under the agreement, Chiesi will be responsible for the distribution of Veloxis’ LCP-Tacro product in addition to promoting the drug and handling pricing and reimbursement for its use
Afrezza is an investigational, ultra rapid-acting mealtime insulin therapy, administered using MannKind’s to-be-marketed next-generation inhaler. MannKind chairman and chief executive officer Alfred Mann said the completion of the